Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals

Clinical Microbiology and Infection

Volumn 17, Issue 9, 2011, Pages 1366-1371

  Garbino, J ^a   Fluckiger, U ^b   Elzi, L ^b   Imhof, A ^c   Bille, J ^d   Zimmerli, S ^e  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

Corticosteroid treatment; Critically ill; Invasive aspergillosis; Non neutropenic hosts; Opportunistic infection

Indexed keywords

ANTIFUNGAL AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; AGE; AGE DISTRIBUTION; AGED; ANTIMICROBIAL THERAPY; ARTICLE; AUTOPSY; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CHRONIC LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; FEMALE; FUNGAL SINUSITIS; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTENSIVE CARE UNIT; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; SWITZERLAND; TEACHING HOSPITAL; THORAX RADIOGRAPHY;

EID: 80051905166     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03402.x     Document Type: Article

References (26)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803; quiz 804-805.
2. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.
3. Ribaud P, Chastang C, Latgé JP et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999; 28: 322-330.
4. Stevens DA, Kan VL, Judson MA et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 696-709.
5. Montoya JG, Chaparro SV, Celis D et al. Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis 2000; 37 (suppl 3): S281-S292.
6. Meersseman W, Vandecasteele SJ, Wilmer A et al. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621-625.
7. Gavalda J, Len O, San Juan R et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis 2005; 41: 52-59.
8. Cornillet A, Camus C, et Nimubona S et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006; 43: 577-584.
9. Barrault C, Thabut D, Duguet A et al. Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series. BMC Gastroenterol 2007; 7: 2.
10. Guinea J, Torres-Narbona M, Gijón P et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2010; 16: 870-877.
11. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2009; 9: R191-R199.
12. Meersseman W, Lagrou K, Maertens J et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177: 27-34.
13. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
14. Faber J, Moritz N, Henninger N. Rapid detection of common pathogenic Aspergillus species by a novel real-time PCR approach. Mycoses 2009; 52: 228-233.
15. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005; 43 (suppl 1): S207-S238.
16. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609-622.
17. Segal BH, DeCarlo ES, Kwon-Chung KJ et al. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 1998; 77: 345-354.
18. Denning DW, Riniotis K, Dobrashian R et al. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37 (suppl 3): S265-S280.
19. Rello J, Esandi ME, Mariscal D et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26: 1473-1475.
20. Bulpa PA, Dive AM, Garrino MG et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 2001; 27: 59-67.
21. Muquim A, Dial S, Menzies D. Invasive aspergillosis in patients with chronic obstructive pulmonary diseases. Can Respir J 2005; 12: 199-204.
22. Vandewoude KH, Blot SI, Depuydt P et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 2006; 10: R31: ccforum.com/content/10/1/R31.
23. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007; 30: 782-800.
24. Li D, Chen L, Tao R et al. Hospital-acquired invasive pulmonary aspergillosis in patients with hepatic failure. BMC Gastroenterol 2008; 8: 32-39.
25. Samarakoon P, Soubani AO. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis 2008; 5: 19-27.
26. Kaiser P, Thurnheer R, Moll C et al. Invasive aspergillosis in non-neutropenic patients. Eur J Intern Med 2009; 20: e131-e133.